N4 PHARMA PLC
Develops a silica nanoparticle delivery system for nucleic acid-based treatments.
N4P | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYW8QM32
- LEI:
- 213800I841D2RKMFK955
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, EC3V 0HR LONDON
- Website:
- https://n4pharma.com/
Description
N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-18 13:34 |
Holding(s) in Company
|
English | HTML • 52.3 KB | ||
| 2025-02-07 08:00 |
Investor Webinar
|
English | HTML • 14.4 KB | ||
| 2025-02-06 16:06 |
Director/PDMR Shareholding
|
English | HTML • 28.7 KB | ||
| 2025-02-06 08:00 |
Appointment of Commercial Adviser
|
English | HTML • 22.0 KB | ||
| 2025-02-03 17:35 |
Change of Registered Office
|
English | HTML • 11.9 KB | ||
| 2025-02-03 08:00 |
Ananda Pharma Appoints Viridian Capital Advisors
|
English | HTML • 18.2 KB | ||
| 2025-01-27 08:00 |
Investor Webinar
|
English | HTML • 15.5 KB | ||
| 2025-01-22 08:00 |
2025 Kick-Off Webinar
|
English | HTML • 20.3 KB | ||
| 2025-01-16 08:00 |
N4 Pharma Non-Executive Director Q&A
|
English | HTML • 13.6 KB | ||
| 2025-01-08 08:00 |
Directorate Changes
|
English | HTML • 29.1 KB | ||
| 2025-01-07 12:34 |
Total Voting Rights
|
English | HTML • 9.5 KB | ||
| 2024-12-12 08:00 |
N4 101 In Vitro Results
|
English | HTML • 24.2 KB | ||
| 2024-12-04 08:00 |
New Patent Filing
|
English | HTML • 14.7 KB | ||
| 2024-11-28 08:00 |
Grant of Options
|
English | HTML • 46.7 KB | ||
| 2024-11-01 08:00 |
N4 Pharma CEO Q&A Now LIVE
|
English | HTML • 11.5 KB |
Automate Your Workflow. Get a real-time feed of all N4 PHARMA PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for N4 PHARMA PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for N4 PHARMA PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
